Cargando…
Stereotactic body radiation therapy in the treatment of ovarian cancer
BACKGROUND: This study evaluates the outcomes and toxicity of stereotactic body radiation therapy (SBRT) in ovarian cancer. METHODS: This retrospective analysis considered all patients treated with SBRT from 2009 to 2018 with a primary ovarian tumor. Follow-up included PET-CT and CT scans at 2–3 mon...
Autores principales: | Kowalchuk, Roman O., Waters, Michael R., Richardson, K. Martin, Spencer, Kelly, Larner, James M., Irvin, William P., Kersh, Charles R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7222303/ https://www.ncbi.nlm.nih.gov/pubmed/32404167 http://dx.doi.org/10.1186/s13014-020-01564-w |
Ejemplares similares
-
Low‐dose hilar and mediastinal stereotactic body radiation therapy for non‐small cell lung cancer: Analysis of outcomes in patients receiving one or multiple courses of treatment
por: Kowalchuk, Roman O., et al.
Publicado: (2020) -
A single institutional experience with central lung stereotactic body radiation therapy demonstrating encouraging results with increased inter-fraction time
por: Kowalchuk, Roman O., et al.
Publicado: (2021) -
Stereotactic body radiation therapy for empirically treated hypermetabolic lung lesions: a single-institutional experience identifying the Charlson score as a key prognostic factor
por: Kowalchuk, Roman O., et al.
Publicado: (2020) -
Recursive Partitioning Analysis for Local Control Achieved With Stereotactic Body Radiation Therapy for the Liver, Spine, or Lymph Nodes
por: Kowalchuk, Roman O., et al.
Publicado: (2020) -
Effect of histology on stereotactic body radiotherapy for non-small cell lung cancer oligometastatic pulmonary lesions
por: Allen, Alexander J., et al.
Publicado: (2023)